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Abstract
 
The immune system has evolved specialized cellular and molecular mechanisms for targeting
and regulating immune responses at epithelial surfaces. Here we show that small intestinal in-
traepithelial lymphocytes and lamina propria lymphocytes migrate to thymus-expressed
chemokine (TECK). This attraction is mediated by CC chemokine receptor (CCR)9, a
 
chemoattractant receptor expressed at high levels by essentially all CD4
 
1
 
 and CD8
 
1
 
 T lympho-
cytes in the small intestine. Only a small subset of lymphocytes in the colon are CCR9
 
1
 
, and
lymphocytes from other tissues including tonsils, lung, inflamed liver, normal or inflamed skin,
inflamed synovium and synovial fluid, breast milk, and seminal fluid are universally CCR9
 
2
 
.
TECK expression is also restricted to the small intestine: immunohistochemistry reveals that in-
tense anti-TECK reactivity characterizes crypt epithelium in the jejunum and ileum, but not in
other epithelia of the digestive tract (including stomach and colon), skin, lung, or salivary
gland. These results imply a restricted role for lymphocyte CCR9 and its ligand TECK in the
small intestine, and provide the first evidence for distinctive mechanisms of lymphocyte re-
cruitment that may permit functional specialization of immune responses in different segments
of the gastrointestinal tract. Selective expression of chemokines by differentiated epithelium
may represent an important mechanism for targeting and specialization of immune responses.
Key words: leukocyte • gastrointestinal tract • trafﬁcking • epithelium • lamina propria 
lymphocytes
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Introduction
 
Recent studies have shown that certain constitutively
expressed chemokines play an important role in regulating
homeostatic lymphocyte recirculation through secondary
lymphoid organs, whereas others may help control tissue-
specific targeting of lymphocytes to extralymphoid organs
(1, 2). The first examples of chemokines that participate in
nonlymphoid tissue–selective lymphocyte targeting have
recently been identified: thymus and activation-regulated
chemokine (TARC; reference 3) and cutaneous T cell–
attracting chemokine (CTACK; reference 4). TARC is con-
stitutively expressed by venular endothelium in the skin
and can trigger rapid adhesion of circulating skin-homing
memory lymphocytes expressing CC chemokine receptor
(CCR)4 (3). CTACK, expressed by skin epidermal kerati-
nocytes, is chemotactic for a similar subset of skin-homing
memory lymphocytes (4). Together, these two chemokines
and their receptors may regulate memory lymphocyte ad-
hesion to cutaneous vascular endothelium and subsequent
entry into and localization within the skin.
Like the skin, mucosal sites such as the gastrointestinal
tract are constantly exposed to potential pathogens, and
thus present highly specialized challenges to the immune
system. Here we have explored the potential for specialized
chemokine involvement in lymphocyte localization in the
gastrointestinal tract. The chemokine thymus-expressed
chemokine (TECK) is highly expressed at the message level
in the small intestine (5–7), and has recently been localized
by in situ hybridization to the intestinal epithelium in the
mouse. Interestingly, CCR9, the only known receptor for
TECK, is expressed by discrete subsets of circulating mem-
ory CD4
 
1
 
 and CD8
 
1
 
 lymphocytes expressing the intestinal
homing receptor 
 
a
 
4
 
b
 
7
 
, but not by other systemic memory
lymphocyte subsets (5), suggesting that CCR9 may be a re-
ceptor used preferentially by lymphocytes involved in as-
pects of gut immunity. Consistent with this, CCR9 is ex-
pressed on lymphocytes isolated from human small intestine
(5). Together, these studies suggest a role for TECK and
CCR9 in the intestinal immune compartment, but the ex-
tent to which this chemokine receptor–ligand pair is specif-
ically associated with the intestinal compartment versus
other mucosal and epithelial sites remains unclear.
Here, we report an extraordinarily selective association of
both epithelia expressing TECK and lymphocytes expressing
CCR9 with the immune compartment of the small intes-
tine. The results support a novel paradigm in which epithe-
lial cell–expressed chemokines can provide specific “ad-
dressin” signals controlling cellular recruitment and thus the
character of immune responses at different epithelial surfaces.
 
Materials and Methods
 
Abs and Reagents.
 
Anti–human CCR9 mAbs 3C3 (mouse
IgG
 
2b
 
) and 96-1 (mouse IgG
 
1
 
) have been described (5). Anti–
human TECK mAb 52513.111 (mouse IgG
 
2b
 
) and isotype control
mAb 20116.11 (mouse IgG
 
2b
 
) were from R&D Systems. Directly
conjugated mouse anti–human CD3-FITC (IgG
 
1
 
, clone
UCHT1), TCR
 
ab
 
-FITC (IgM, clone T10B9.1A-31), CD4-
 
allophycocyanin (IgG
 
1
 
, clone RPA-T4), and CD8-PE (IgG
 
1
 
, clone
RPA-T8) were from BD PharMingen. BSA fraction V, dithio-
threitol, sodium azide, EDTA, and olive oil were from Sigma-
Aldrich. Crude collagenase (CLS-2) was from Worthington Bio-
chemical Corp. Recombinant human TECK and IFN-inducible
T cell 
 
a 
 
chemoattractant (I-TAC) were from PeproTech.
 
Tissue Sources and Lymphocyte Isolation.
 
Normal human je-
junum, ileum, colon, lung, facial skin, inflamed liver, and inflamed
synovial tissue were from patients undergoing various surgical pro-
cedures. Synovial fluid was from patients undergoing diagnostic
arthroscopy. Breast milk was obtained from nursing volunteers,
and seminal fluid was obtained from normal male volunteers. All
human subject protocols were approved by the Institutional Re-
view Boards at Stanford University, the University of Oslo,
Leicester University, or Robert Wood Johnson Medical School.
Lymphocytes from the epithelium and lamina propria of hu-
man intestine were isolated as described previously (8). Lympho-
cytes were isolated from normal human skin by first using a razor
blade to separate the epidermis and a portion of the dermis from
the lower dermis and subcutaneous fat. The epidermal pieces
were cut into strips and incubated in cold 5 mM EDTA/HBSS
for 120 min with vigorous stirring. The supernatant from this step
was spun down to obtain released lymphocytes, and the remain-
ing strips were crushed through a 50 mesh strainer to obtain addi-
tional lymphocytes. To obtain lymphocytes from inflamed skin,
delayed-type hypersensitivity reactions were induced by poison
oak application, or by intradermal injection of 
 
Candida
 
 allergen
(0.1 ml Candin
 
®
 
; Allermed Laboratories, Inc.) in an allergic vol-
unteer, and epidermal blisters were raised on the affected volar as-
pect of the forearm as described previously (9), and after 24 h,
lymphocyte-containing blister fluid was drained. Lymphocytes
were isolated from normal lung by finely mincing the tissue and
sieving the resulting suspension through gauze. Lymphocytes
were isolated from explant livers by first cutting the liver into
small 1-cm
 
2
 
 pieces, washing in RPMI 1640 supplemented with
10% fetal bovine serum, and then homogenizing into a cell sus-
pension with a Stomacher 400 (Seward). Lymphocytes were iso-
lated from synovial tissue as described (10). Synovial fluid, breast
milk, and seminal fluid were diluted with FACS
 
®
 
 buffer (PBS
supplemented with 0.1% azide and 1% BSA), centrifuged at 250 
 
g
 
,
and resuspended in FACS
 
®
 
 buffer. Cell suspensions from liver,
synovial fluid, breast milk, and seminal fluid were layered over
Ficoll (Amersham Pharmacia Biotech) and the mononuclear cell
layer was used for FACS
 
®
 
 analysis. We found that the treatments
required to dissociate these tissues did not affect CCR9 expres-
sion, and other lymphocyte markers such as LFA-1 were positive
on all isolated lymphocyte populations (data not shown).
 
FACS
 
®
 
 Analysis.
 
Tissue lymphocytes were stained and gated
for CD3 (or TCR
 
ab
 
) expression, then further subdivided by CD4
or CD8 expression. Unconjugated anti-CCR9 mAbs (or isotype-
matched control mAbs) were detected using a biotinylated horse
anti–mouse IgG secondary Ab (Vector Laboratories) and streptavi-
din–peridinine chlorophyll protein (BD PharMingen). Four-color
flow cytometry was done on a FACSCalibur™ (Becton Dickin-
son) using CELLQuest™ software, v3.1 (Becton Dickinson).
 
Tissue Northern and Dot Blots.
 
PolyA
 
1
 
 mRNA from various
human tissues was purchased from CLONTECH Laboratories,
Inc. or Clemente Associates, Inc., separated on a 1.5% formalde-
hyde-agarose gel, blotted, and probed with 
 
32
 
P-labeled cDNA us-
ing standard protocols. A human MTE™ array of multiple hu-
man tissue polyA
 
1
 
 mRNAs (CLONTECH Laboratories, Inc.)
was hybridized according to the manufacturer’s instructions. 
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In Situ Hybridization.
 
A 348-bp digoxigenin (DIG)-labeled
riboprobe was generated from the coding region of human
TECK using the DIG RNA labeling kit according to the manu-
facturer’s directions (Boehringer). All further steps were per-
formed as described (11). In brief, frozen tissue sections were
fixed in 4% paraformaldehyde and washed in 0.1% active dieth-
ylpyrocarbonate. Hybridization was performed in a solution of
50% formamide, 5
 
3
 
 SSC, 50 
 
m
 
g/ml yeast tRNA, 100 
 
m
 
g/ml he-
parin, 1
 
3
 
 Denhardt solution, 0.1% Tween 20, 0.1% 3-[(3-cho-
lamidopropyl)-dimethyl-ammonio]-1-propanesulfonate, and 5 mM
EDTA overnight at 59
 
8
 
C with 500 ng/ml of riboprobe. A
high stringency wash was performed in the following sequence:
2
 
3
 
 SSC (30 min), 2
 
3
 
 SSC (1 h, 65
 
8
 
C), and 0.1
 
3
 
 SSC (1 h,
65
 
8
 
C). DIG was visualized by means of an alkaline phosphatase–
conjugated sheep anti-DIG and nitro blue tetrazolium chloride/
5-bromo-4 chloro-3 indolyl phosphate, disodium salt substrate
according to the manufacturer (Boehringer).
 
Immunohistology.
 
Frozen sections of various optimal cutting
temperature–embedded tissues were fixed for 10 min at room
temperature in 4% paraformaldehyde/PBS, washed for 10 min in
PBS, blocked with 100% goat serum for 10 min, then incubated
with 2.5 
 
m
 
g/ml mouse anti–human TECK Ab (R&D Systems)
or an isotype control mAb (R&D Systems) in 25% goat serum/
PBS (GIBCO BRL), washed once in PBS, incubated with a 1:50
dilution of a goat anti–mouse-PE F(ab
 
9
 
)
 
2
 
 secondary Ab (BD
PharMingen), washed, and visualized by confocal microscopy.
Serial tissue sections were stained with a mouse anti–human
“pan” cytokeratin Ab (IgG
 
1
 
, clone C-11; Sigma-Aldrich) to
highlight the epithelial layers.
 
Chemotaxis of Intestinal Lymphocytes.
 
Chemotaxis assays were
performed essentially as described (3) in RPMI 1640 with 0.5%
BSA for 3 h. 10
 
6
 
 intraepithelial lymphocytes (IELs) or 5 
 
3
 
 10
 
5
 
lamina propria lymphocytes (LPLs), isolated from jejunal sections
removed during gastric bypass surgeries as described previously
(5), were placed in the top well of each insert. For Ab blockade
experiments, IELs or LPLs were incubated with 40 
 
m
 
g/ml of
anti-CCR9 mAb 3C3, control mouse IgG
 
2b
 
 (clone 49.2; BD
PharMingen), or medium alone for 10 min at 4
 
8
 
C before addi-
tion to the insert.
 
Results and Discussion
 
We initially asked whether small intestinal lymphocytes
could chemotax to TECK, as predicted by their expression
of the known TECK receptor CCR9 (5). In a standard
transwell assay, both IELs (data not shown) and LPLs mi-
grated to TECK with the typical bell-shaped dose–response
curve characteristic of chemotaxis, with an optimal TECK
concentration of 
 
z
 
300 nM (Fig. 1 A). Importantly, anti-
CCR9 mAb 3C3 reduced migration almost to background
levels (Fig. 1 B). In contrast, migration to I-TAC, a
chemokine that signals through the independent receptor
CXCR3 (Fig. 1 C), was not inhibited by anti-CCR9. We
conclude that small intestinal lymphocytes migrate to
TECK, and that this response is predominantly, or exclu-
sively, mediated through CCR9.
The intestines have historically been considered part of a
“common mucosal immune system” (12), so we were in-
terested in the potential association of infiltrating CCR9
 
1
 
lymphocytes, and of TECK, with other regions of the gas-
trointestinal tract, with other mucosal epithelia, and with
 
nonmucosal epithelial tissues. Essentially all CD4
 
1
 
 and
CD8
 
1
 
 T cells in both the intraepithelial and lamina propria
compartments of the jejunum displayed high levels of
CCR9 (Fig. 2, A and B). Lymphocytes isolated from an il-
eal specimen displayed an intermediate phenotype, with
 
z
 
50% of CD4
 
1
 
 and CD8
 
1
 
 lymphocytes bearing CCR9
(data not shown). Interestingly, a smaller percentage of the
lymphocytes isolated from the colon expressed CCR9
compared with jejunal lymphocytes (Fig. 2 J). These results
suggest an unexpected level of differentiation between, and
specialization of, lymphocytes in different segments of the
gastrointestinal tract.
Even more surprising was the complete lack of CCR9
expression on CD4
 
1
 
 and CD8
 
1
 
 lymphocytes infiltrating a
variety of other normal and inflamed mucosal and other
epithelia-associated tissues. Lymphocytes from normal lung
tissue (Fig. 2 C) were uniformly CCR9
 
2
 
, as were lympho-
cytes from hepatitis C–infected liver (Fig. 2 D). Lympho-
cytes in breast milk (Fig. 2 E) and seminal fluid (data not
shown), secretions of two epithelial glands, were also
CCR9
 
2
 
. Lymphocytes infiltrating normal (Fig. 2 F) and
inflamed (delayed-type hypersensitivity to 
 
Candida 
 
or con-
tact hypersensitivity to poison oak; Fig. 2 G) skin were uni-
formly negative as well, as were lymphocytes infiltrating in-
flamed joints (in the synovial tissue or the synovial fluid) in
rheumatoid arthritis (Fig. 2, H and I) and other arthropities
including psoriatic arthritis (synovial fluid), osteoarthritis
(synovium and synovial fluid), ankylosing spondylitis (syn-
ovium), and acetabular osteolysis (synovium; data not
shown). All lymphocytes analyzed by flow cytometry were
isolated by mechanical means, obviating the need for enzy-
matic digestion that might alter cell surface antigen levels.
(The sole exception were the lymphocytes isolated from
synovium; in this case, parallel treatment of peripheral
blood lymphocytes with collagenase confirmed lack of al-
teration in detectable CCR9 levels by the isolation proce-
dure used.) Similar lack of CCR9 expression was found
Figure 1. Human LPL che-
motaxis to human TECK is
mediated by CCR9. (A) Whole
populations of LPLs isolated
from the human small intestine
chemotax efficiently to hTECK.
TECK-induced chemotaxis is
mediated exclusively by the
chemokine receptor CCR9
since (B) the anti-CCR9 Ab
3C3 (40 mg/ml) blocks chemo-
taxis to hTECK whereas (C) the
same Ab does not block chemo-
taxis to hI-TAC, which signals
through CXCR3 expressed on
virtually all LPLs. Data in A are
the mean 6 SD of duplicate
wells (n 5 3) and data in B and
C are the mean 6 SD of tripli-
cate wells (n 5 2). 250 nM
TECK and 100 nM I-TAC were
used in B and C. 
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Figure 2. CCR9 expression is highly specific for CD41 and CD81
lymphocytes infiltrating the small intestine. FACS® analysis reveals
that CCR9 is expressed on virtually all CD41 and CD81 lympho-
cytes in the (A) IEL and (B) LPL compartments of the jejunum. In-
terestingly, CCR9 was not detected on lymphocytes isolated from
(C) normal lung, (D) hepatitis C virus (HCV)-infected liver, (E)
breast milk, (F) normal skin, (G) inflamed skin (delayed-type hyper-
sensitivity [DTH]), (H) rheumatoid arthritis (RA) synovium, and (I)
rheumatoid arthritis synovial fluid, and (J) a smaller percentage of co-
lon lymphocytes expresses CCR9 compared with jejunal lympho-
cytes (2,000 cells in each panel). (A–I) Isotype-matched control Ab
staining shown as dotted lines. Percentage of CCR91 cells based on a
marker encompassing 5% of isotype control–stained cells in both his-
togram and dot blots. Data are representative of three jejunum, four
colon, four liver, two breast milk, four normal skin, four inflamed
skin, four synovium, and four synovial fluid samples.
 
with two independent anti-CCR9 mAbs. Thus, although
not all tissues in the body were examined, the results sug-
gest a unique association of the CCR9 with T lymphocytes
involved in small intestinal immunity.
We reasoned that the CCR9 ligand TECK could play an
important role in the selective homing and localization of
CCR9
 
1
 
 lymphocytes if it were also restricted in expression
to the small intestine. Consistent with earlier studies in hu-
mans, TECK message was abundant in human thymus and
various regions of the small intestine (Fig. 3, A and B), but
was not detectable in the colon (Fig. 3, A and B). In addi-
tion, we failed to detect TECK message in other epithelial
tissues including the skin, kidney, trachea, lung, placenta,
bladder, adrenal gland, thyroid gland, salivary gland, pros-
tate gland, and mammary gland (Fig. 3, A and B). These
results, together with a recent report on TECK expression
in mice (7), are consistent with restricted TECK expression
in the small intestine, although in such bulk tissue mRNA
preparations, significant TECK expression by a restricted
cell population cannot be excluded.
We therefore used morphologic approaches to assess cel-
lular sites of TECK expression more directly. In situ hy-
bridization demonstrated intense expression of TECK mes-
sage limited to jejunal epithelium, especially the epithelium
in the crypts of Lieberkühn, with decreasing levels in epi-
thelial cells moving up the villus (Fig. 3 C). The same ex-
pression pattern was observed in the ileum (data not
shown). No detectable TECK hybridization was observed
in two independent colon, two stomach, and two duode-
num specimens. Most important, however, is the pattern of
TECK expression at the protein level. Immunofluores-
cence staining with anti-TECK mAbs revealed strong
staining in the small intestinal epithelium, especially in the
crypts and lower villus epithelium (consistent with the pat-
tern of in situ hybridization) (Fig. 3 D). Isotype-matched
control Abs were negative (Fig. 3 D, inset). Importantly,
no specific TECK reactivity was observed in the epithe-
lium of five separate colon samples (Fig. 3 F), in the epithe-
lia of four samples of normal skin (Fig. 3 G), inflamed pso-
riatic skin (Fig. 3 H), or hives (data not shown), lung765 Kunkel et al. Brief Definitive Report
Figure 3. TECK is highly expressed by
small intestinal epithelium but not epithelia
in other tissues. (A and B) Dot blot and
northern blot analysis of TECK mRNA ex-
pression in various human mucosal and epi-
thelial tissues demonstrates highly preferen-
tial expression of TECK message in the
thymus and various segments of the small
intestine, but not other epithelial tissues
such as the skin, kidney, trachea, lung, pla-
centa, bladder, adrenal gland, thyroid gland,
salivary gland, prostate gland, and mammary
gland. GAPDH, glyceraldehyde 3-phos-
phate dehydrogenase. (C) Further analysis
by in situ  hybridization localizes TECK
mRNA expression specifically to the intes-
tinal epithelium in the crypts of Lieberkühn
and (D and E) immunohistochemistry local-
izes TECK protein to the epithelium of the
crypts of Lieberkühn and villi in the small
intestine. No TECK protein reactivity is
detected in the (F) colon or in (G) epithelia
from a variety of other human tissues in-
cluding (G) normal skin, (H) inflamed pso-
riatic skin, (I) lung bronchioles, (J) salivary
gland, or (K) stomach. Ubiquitin staining of
the dot blot array revealed that mRNA
loading of each tissue was relatively consis-
tent. In situ data are representative of three
jejunum samples, and immunohistochemis-
try data are representative of five jejunum,
five colon, four normal skin, three inflamed
skin (two psoriatic and one hives), three
lung, three salivary gland, and four stomach
samples. (D–K) Arrowheads or asterisks
highlight epithelia.766 Small Intestinal Memory T Cells Defined by Expression of CCR9
bronchioles in three different samples (Fig. 3 I), in three
salivary glands (Fig. 3 J), or in four samples of stomach (Fig.
3 K). Although expression below detectable limits cannot
be ruled out, we conclude that TECK is produced selec-
tively at high levels by epithelial cells of the small intestine,
particularly the crypt epithelium in the jejunum and ileum,
consistent with a highly selective role for TECK in the
small intestinal immune compartment.
In addition to its ability to attract CCR91 small intestinal
tissue lymphocytes, TECK can attract the small subset of
circulating CCR91 memory cells in human blood (5).
These cells constitute a discrete subset of memory cells ex-
pressing the intestinal homing receptor a4b7, an integrin
receptor for the mucosal vascular addressin MAdCAM-1
(13). Venules expressing MAdCAM-1 in the gut wall are
prominent in the basilar lamina propria near the crypts of
Lieberkühn (14). Thus, it is attractive to propose that in the
jejunum, the juxtaposition of MAdCAM-1–expressing ves-
sels with TECK-expressing epithelium, combined with the
expression of a4b7 by circulating CCR91 memory cells,
may lead to the selective recruitment of a specialized subset
of circulating “small intestine homing” lymphocytes by se-
quential action of a4b7, LFA-1, and CCR9/TECK. In this
variant of the multistep model of lymphocyte recruitment
(15), CCR9 could function primarily in selective transen-
dothelial migration after arrest. Alternatively, epithelium-
expressed TECK may also diffuse to and be presented by
the vascular endothelium (16) to support the integrin acti-
vation required for lymphocyte arrest on lamina propria
endothelium. Once lymphocytes have entered the lamina
propria of the small intestine, localization within specific
compartments such as the epithelium likely occurs by step-
by-step migration of lymphocytes through chemokine gra-
dients (17). For instance, CCR91 lymphocytes selectively
recruited into the lamina propria by TECK may then be
directed to the villous epithelium by additional chemoat-
tractants, e.g., stromal cell–derived factor 1a, which seems
to be differentially expressed by villous epithelial cells (18).
Interestingly, recent studies have revealed selective ex-
pression of a distinct chemokine, CTACK, by cutaneous
epithelial cells (keratinocytes; reference 4). CTACK selec-
tively attracts circulating cutaneous memory T cells (4).
Moreover, like TECK in the small intestinal epithelium,
CTACK appears to be constitutively expressed by skin ke-
ratinocytes (4). Thus, TECK and CTACK may represent
the critical defining components of the small intestinal and
cutaneous immune environments, respectively.
In conclusion, our results suggest a highly restricted ex-
pression of TECK by small intestinal epithelial cells, and of
its receptor CCR9 by lymphocytes infiltrating the small in-
testine. These results suggest a previously unsuspected spe-
cialization of chemokine receptor–ligand expression and
hence, of homing mechanisms to different segments of the
gastrointestinal tract. Moreover, in conjunction with recent
studies revealing restricted epithelial expression of a related
CC chemokine, CTACK, by skin keratinocytes, our find-
ings suggest a novel paradigm in which the constitutive ex-
pression of chemokine “addressins” by epithelial cells can
control the recruitment and localization of specialized lym-
phocytes, and thus the character of immune responses at
different epithelial surfaces.
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